Midkine (MK) is a heparin-binding growth factor that was originally discovered as the product of a retinoic acid-responsive gene during the differentiation of embryonal carcinoma cells (Kadomatsu et al, 1988; Tomomura et al, 1990; Muramatsu, 2002). The gene discussed is MDK; the disease is embryonal carcinoma.